Atypical Femur Fractures: Addressing the Problem from a Patient-Centered Perspective скачать в хорошем качестве

Atypical Femur Fractures: Addressing the Problem from a Patient-Centered Perspective

Osteoporotic fractures lead to substantial morbidity, mortality, and socioeconomic impact. For example, hip fractures are associated with an approximate 25% one-year mortality and lead to 65,000 deaths each year in the United Stated alone, and over half of the patients who experience hip fractures are permanently incapacitated. Despite these devastating consequences of hip and other osteoporotic fractures, rates of pharmacological treatment, even in patients at high fracture risk, are declining. As highlighted by an article by Gina Kolata in the New York Times, part of the reason for this decline is patient and physician concerns about potential side-effects related to bisphosphonate therapy, particularly for atypical femur fractures (AFFs). In this webinar, Dr. Sundeep Khosla (Mayo Clinic) and three additional bone experts will discuss the scope of the problem of AFFs, the benefits vs risks of pharmacological treatment of osteoporosis, and most importantly, approaches to mitigate the risks of AFF. Critical to this effort is building patient trust and engagement, and potential approaches to this important goal will also be reviewed. What You Will Learn: • The benefits vs risk of pharmacological treatment of patients at increased fracture risk • Potential approaches to early identification of patients at risk for AFFs • How we can begin to engage patients as true partners in the treatment of osteoporosis Speaker: Sundeep Khosla, M.D. Mayo Foundation Distinguished Investigator and Director of the Center for Clinical and Translational Science at Mayo Clinic Deborah Gold, Ph.D. Professor of Medical Sociology at Duke University Medical Center Malachi J. McKenna, M.D., FACP, CCD Clinical Director of the Metabolism Laboratory and Co-Director of the DXA Unit at St. Vincent’s University Hospital. He is UCD Clinical Professor, School of Medicine, University College Dublin Elizabeth Shane, M.D. Professor of Medicine, Vice Chair of Medicine for Clinical and Epidemiological Research at Columbia University, College of Physicians and Surgeons in New York City Original Broadcast: January 18th, 2017